Amputations of the toe and middle of the foot were the most common, but leg amputations below and above the knee also occurred.
Company asks FDA to approve ferric citrate for iron deficiency anemia in patients with non-dialysis dependent chronic kidney disease.
Noctiva is taken 30 minutes before bed and is designed to increase absorption of water through the kidneys.
The drug is indicated for treating patients with locally advanced or metastatic disease that progresses despite platinum-containing chemotherapy.
After analyzing new data, the FDA again warns that the diabetes drug may be associated with an increased risk for bladder cancer.
Updated label for patiromer now recommends the drug be taken at least 3 hours before or after other oral medications.
The new FDA warning alerts prescribers to the abuse potential of testosterone.
Labeling changes will alert prescribers to the abuse potential of testosterone and the serious adverse effects.
Labeling information will include data showing the drug reduces the risk of radiographic progression versus bicalutamide.
While ADFs of opioids may help mitigate the risk of opioid abuse, they have limitations as well.
Once-daily injection to improve glycemic control, along with diet and exercise.
Fluoroquinolones such as Cipro, Levaquin should be reserved for life-threatening infections.
The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS) is absorbed by the body after about 3 years.
Calcifediol formulation is indicated for CKD stage 3 or 4 patients with secondary hyperparathyroidism associated with vitamin D insufficiency.
The Food and Drug Administration (FDA) announced it is strengthening the current warning about the risk of acute kidney injury for drug products containing canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).
Renal and Urology News Articles
- Study: Ureterolithotripsy Best for Large Proximal Ureteral Stones
- Post-RP Radiotherapy Benefits Selected Men With Elevated PSA
- Erectile Dysfunction Risk Higher in Gout Patients
- Multimodal Therapy Found to Benefit Men With LN-positive PCa
- Switch to an Iron-Based Binder Found to Improve Phosphorus Lowering
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)